AAAAAA

   
Results: 1-24 |
Results: 24
Endocytic disturbances distinguish among subtypes of Alzheimer's disease and related disorders
Authors: Cataldo, A Rebeck, GW Ghetti, B Hulette, C Lippa, C Van Broeckhovan, C van Duijn, C Cras, P Bogdanovic, N Bird, T Peterhoff, C Nixon, R
Citation: A. Cataldo et al., Endocytic disturbances distinguish among subtypes of Alzheimer's disease and related disorders, ANN NEUROL, 50(5), 2001, pp. 661-665
Influence of the prion protein and the apolipoprotein E genotype on the Creutzfeldt-Jakob Disease phenotype
Authors: Van Everbroeck, B Croes, EA Pals, P Dermaut, B Jansen, G van Duijn, CM Cruts, M Van Broeckhoven, C Martin, JJ Cras, P
Citation: B. Van Everbroeck et al., Influence of the prion protein and the apolipoprotein E genotype on the Creutzfeldt-Jakob Disease phenotype, NEUROSCI L, 313(1-2), 2001, pp. 69-72
The many faces of human prion diseases in Belgium and the world
Authors: Van Everbroeck, B Pals, P Quoilin, S Martin, JJ Cras, P
Citation: B. Van Everbroeck et al., The many faces of human prion diseases in Belgium and the world, ACT NEUR BE, 101(2), 2001, pp. 81-87
Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: A quantitative examination
Authors: Irwin, SA Patel, B Idupulapati, M Harris, JB Crisostomo, RA Larsen, BP Kooy, F Willems, PJ Cras, P Kozlowski, PB Swain, RA Weiler, IJ Greenough, WT
Citation: Sa. Irwin et al., Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: A quantitative examination, AM J MED G, 98(2), 2001, pp. 161-167
Early diagnosis of cerebral fat embolism syndrome by diffusion-weighted MRI (starfield pattern)
Authors: Parizel, PM Demey, HE Veeckmans, G Verstreken, F Cras, P Jorens, PG De Schepper, AM
Citation: Pm. Parizel et al., Early diagnosis of cerebral fat embolism syndrome by diffusion-weighted MRI (starfield pattern), STROKE, 32(12), 2001, pp. 2942-2944
Recent developments in Alzheimer's disease
Authors: Cras, P
Citation: P. Cras, Recent developments in Alzheimer's disease, ACT CLIN B, 56(5), 2001, pp. 269-278
Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation
Authors: Kumar-Singh, S Dewachter, I Moechars, D Lubke, U De Jonghe, C Ceuterick, C Checler, F Naidu, A Cordell, B Cras, P Van Broeckhoven, C Van Leuven, F
Citation: S. Kumar-singh et al., Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation, NEUROBIOL D, 7(1), 2000, pp. 9-22
Mapping of serotonin 5-HT4 receptor mRNA and ligand binding sites in the post-mortem human brain
Authors: Bonaventure, P Hall, H Gommeren, W Cras, P Langlois, X Jurzak, M Leysen, JE
Citation: P. Bonaventure et al., Mapping of serotonin 5-HT4 receptor mRNA and ligand binding sites in the post-mortem human brain, SYNAPSE, 36(1), 2000, pp. 35-46
Experimental gerontology in Belgium: from model organisms to age-related pathologies
Authors: Toussaint, O Baret, PV Brion, JP Cras, P Collette, F De Deyn, PP Geenen, V Kienlen-Campard, P Labeur, C Legros, JJ Neve, J Octave, JN Pierard, GE Salmon, E de Aguilar, PVB Van der Linden, M Leuven, FV Vanfleteren, J
Citation: O. Toussaint et al., Experimental gerontology in Belgium: from model organisms to age-related pathologies, EXP GERONT, 35(8), 2000, pp. 901-916
Familial Creutzfeldt-Jakob disease in a patient carrying both a presenilin1 missense substitution and a prion protein gene insertion
Authors: Dermaut, B Cruts, M Backhovens, H Lubke, U Van Everbroeck, B Sciot, R Dom, R Martin, JJ Van Broeckhoven, C Cras, P
Citation: B. Dermaut et al., Familial Creutzfeldt-Jakob disease in a patient carrying both a presenilin1 missense substitution and a prion protein gene insertion, J NEUROL, 247(5), 2000, pp. 364-368
Abciximab in acute ischemic stroke - A randomized, double-blind, placebo-controlled, dose-escalation study
Authors: Adams, HP Bogousslavsky, J Barnathan, E Brott, T Fisher, M Furlan, AJ Graffagnino, C Kappelle, J Kothari, R Leclerc, JR Moulin, T Polzer, J Torner, J Worley, S Haley, CE Day, JH Levine, SR Thompson, JLP Sherman, DG Sane, DC Maley, JE Grimsman, KJ Maeder, M Clarke, WR Anderson, K Cook, R FitzPatrick, S Peeters, A Cras, P Blecic, S Laloux, P Chatel, M Mahagne, H Moulin, T Hacke, W Diener, HC Bogousslavsky, J Maeder, M Kappelle, LJ Vermulen, M Kwa, VIH Franke, CL Jacoby, M Libman, R Hsu, C Kothari, R Raps, EC Kasner, SE Scott, P Karanjia, P Heiselman, D Graffagnino, C Graham, G Akins, PT Brott, T Meschia, J Furlan, AJ Gordon, D Jackson, CM Starkman, S Wityk, R Worley, S Adams, HP Belden, JR Dashe, J Fisher, M Gomez, C Hwang, TL Jichici, D Thompson, D Adams, HP Barnathan, E Bogousslavsky, J Brott, T Fisher, M Furlan, AJ Hacke, W Kappelle, J Kothari, R Leclerc, JR Moulin, T Polzer, J Scott, P Torner, J
Citation: Hp. Adams et al., Abciximab in acute ischemic stroke - A randomized, double-blind, placebo-controlled, dose-escalation study, STROKE, 31(3), 2000, pp. 601-609
Retrospective study of Creutzfeldt-Jakob disease in Belgium: neuropathological findings
Authors: Van Everbroeck, B Pals, P Dziedzic, T Dom, R Godfraind, C Sciot, R Brucher, JM Martin, JJ Cras, P
Citation: B. Van Everbroeck et al., Retrospective study of Creutzfeldt-Jakob disease in Belgium: neuropathological findings, ACT NEUROP, 99(4), 2000, pp. 358-364
Immunoreactivity of the monoclonal antibody F89/160.1.5 for human prion protein
Authors: Van Everbroeck, B O'Rourke, KI Cras, P
Citation: B. Van Everbroeck et al., Immunoreactivity of the monoclonal antibody F89/160.1.5 for human prion protein, EUR J HIST, 43(4), 1999, pp. 335-338
Evidence that A beta 42 plasma levels in presenilin-1 mutation carriers donot allow for prediction of their clinical phenotype
Authors: De Jonghe, C Cras, P Vanderstichele, H Cruts, M Vanderhoeven, I Smouts, I Vanmechelen, E Martin, JJ Hendriks, L Van Broeckhoven, C
Citation: C. De Jonghe et al., Evidence that A beta 42 plasma levels in presenilin-1 mutation carriers donot allow for prediction of their clinical phenotype, NEUROBIOL D, 6(4), 1999, pp. 280-287
A retrospective study of Creutzfeldt-Jakob disease in Belgium
Authors: Pals, P Everbroeck, BV Sciot, R Godfraind, C Robberecht, W Dom, R Laterre, C Martin, JJ Cras, P
Citation: P. Pals et al., A retrospective study of Creutzfeldt-Jakob disease in Belgium, EUR J EPID, 15(6), 1999, pp. 517-519
Proteolytic processing of presenilin-1 in human lymphoblasts is not affected by the presence of the I143Tand G384A mutations
Authors: Vanderhoeven, I Cras, P Martin, JJ Van Broeckhoven, C De Jonghe, C
Citation: I. Vanderhoeven et al., Proteolytic processing of presenilin-1 in human lymphoblasts is not affected by the presence of the I143Tand G384A mutations, NEUROSCI L, 274(3), 1999, pp. 183-186
Postmortem examination of two fragile X brothers with an FMR1 full mutation
Authors: Reyniers, E Martin, JJ Cras, P Van Marck, E Handig, I Jorens, HZJ Oostra, BA Kooy, RF Willems, PJ
Citation: E. Reyniers et al., Postmortem examination of two fragile X brothers with an FMR1 full mutation, AM J MED G, 84(3), 1999, pp. 245-249
Improved discrimination of AD patients using beta-amyloid((1-42)) and tau levels in CSF
Authors: Hulstaert, F Blennow, K Ivanoiu, A Schoonderwaldt, HC Riemenschneider, M De Deyn, PP Bancher, C Cras, P Wiltfang, J Mehta, PD Iqbal, K Pottel, H Vanmechelen, E Vanderstichele, H
Citation: F. Hulstaert et al., Improved discrimination of AD patients using beta-amyloid((1-42)) and tau levels in CSF, NEUROLOGY, 52(8), 1999, pp. 1555-1562
Humanization of mouse 5-hydroxytryptamine(1B) receptor gene by homologous recombination: In vitro and in vivo characterization
Authors: Bonaventure, P Umans, L Bakker, MHM Cras, P Langlois, X Luyten, WHML Megens, AAHP Serneels, L Van Leuven, F Leysen, JE
Citation: P. Bonaventure et al., Humanization of mouse 5-hydroxytryptamine(1B) receptor gene by homologous recombination: In vitro and in vivo characterization, MOLEC PHARM, 56(1), 1999, pp. 54-67
Antigen retrieval in prion protein immunohistochemistry
Authors: Van Everbroeck, B Pals, P Martin, JJ Cras, P
Citation: B. Van Everbroeck et al., Antigen retrieval in prion protein immunohistochemistry, J HIST CYTO, 47(11), 1999, pp. 1465-1470
Processing of apolipoprotein E in cerebrospinal fluid of patients with Alzheimer's disease
Authors: Stevens, I Van Osta, P Geerts, H Verheyen, G Van Hauwaert, ML Cras, P Engelborghs, S De Deyn, PP Martin, JJ Van Broeckhoven, C Moens, L
Citation: I. Stevens et al., Processing of apolipoprotein E in cerebrospinal fluid of patients with Alzheimer's disease, ALZHEIM REP, 1(4), 1998, pp. 257-265
Fatal encephalitis caused by Mycoplasma pneumoniae diagnosed by the polymerase chain reaction
Authors: Ieven, M Demey, H Ursi, D Van Goethem, G Cras, P Goossens, H
Citation: M. Ieven et al., Fatal encephalitis caused by Mycoplasma pneumoniae diagnosed by the polymerase chain reaction, CLIN INF D, 27(6), 1998, pp. 1552-1553
Creutzfeldt-Jakob disease and blood transfusion
Authors: Lopez, MJF Van Everbroeck, B Pals, P Martin, JJ Cras, P
Citation: Mjf. Lopez et al., Creutzfeldt-Jakob disease and blood transfusion, ACT NEUR BE, 98(3), 1998, pp. 247-251
Cervical myelopathy due to rheumatoid arthritis - Case report and review of the literature
Authors: Keersmaekers, A Truyen, L Ramon, E Cras, P De Clerck, L Martin, JJ
Citation: A. Keersmaekers et al., Cervical myelopathy due to rheumatoid arthritis - Case report and review of the literature, ACT NEUR BE, 98(3), 1998, pp. 284-288
Risultati: 1-24 |